Search Results - "Kalyn, Ya B"

Comparative Dynamics of EEG Parameters in Elderly Patients with Depression during Monotherapy and Combined Treatment by Iznak, A. F., Iznak, E. V., Kalyn, Ya. B., Safarova, T. P., Sheshenin, V. S., Gavrilova, S. I.

“…Objective. To perform a comparative analysis of changes in the functional status of the brain by quantitative electroencephalography (EEG) during combined…”
Get full text

Optimization of Antidepressant Therapy in Conditions of the Gerontology Psychiatric Out-Patient Clinic by Gavrilova, S. I., Kalyn, Ya. B., Safarova, T. P., Yakovleva, O. B., Sheshenin, V. S., Kornilov, V. V., Shipilova, E. S.

“…Objective. To carry out a comparative assessment of the efficacy and safety of monotherapy with a new-generation antidepressant (venlafaxin, agomelatine, or…”
Get full text

Experience of the antidepressive therapy with valdoxan (agomelatine) in a psychogeriatric unit of the psychiatric hospital by Kalyn, Ya B, Safarova, T P, Yakovleva, O B, Sheshenin, V S, Kornilov, V V, Shipilova, E S, Gavrilova, S I

“…To assess therapeutic efficacy, tolerability and safety of valdoxan (agomelatine) in the treatment of depression in elderly inpatients of the psychiatric…”
Get more information

Prognosis of Progressive Cognitive Deficit in Elderly Patients with Mild Cognitive Impairment Receiving Long-Term Treatment (3-year observations) by Gavrilova, S. I., Kolykhalov, I. V., Fedorova, Ya. B., Kalyn, Ya. B., Selezneva, N. D., Samorodov, A. V., Myasoedov, S. N., Boksha, I. S.

“…The aim of the present work was to assess individual prognoses for Cerebrolysin treatment efficacy in mild cognitive impairment syndrome (MCIS) and to identify…”
Get full text

Potential of Preventive Treatment of Alzheimer’s Disease: Results of a Three-Year Prospective Open Comparative Trial of the Efficacy and Safety of Courses of Treatment with Cerebrolysin and Cavinton in Elderly Patients with Mild Cognitive Impairment Syndrome by Gavrilova, S. I., Kolykhalov, I. V., Fedorova, Ya. B., Selezneva, N. D., Kalyn, Ya. B., Roshchina, I. F., Odinak, M. M., Emelin, A. Yu, Kashin, A. V., Gustov, A. V., Antipenko, E. A., Korshunova, Yu. A., Davydova, T. A., Messler, G.

“…Studies were performed in three Russian centers (Moscow, St. Petersburg, Nizhnii Novgorod). The cohort consisted of 110 patients whose mental state…”
Get full text

Comparative dynamics of EEG parameters in elderly depressive patients during monotherapy and combined therapy by Iznak, A F, Iznak, E V, Kalyn, Ya B, Safarova, T P, Sheshenin, V S, Gavrilova, S I

“…To compare the changes in brain functional state in combined antidepressive treatment (venlafaxine plus cerebrolysin) vs. monotherapy with the same…”
Get more information

Optimization of the efficacy and safety of antidepressant therapy in patients of a geriatric psychiatric unit by Gavrilova, S I, Kalyn, Ya B, Safarova, T P, Yakovleva, O B, Sheshenin, V S, Kornilov, V V, Shipilova, E S

“…A comparative evaluation of the efficacy and safety of monotherapy with one of the modern antidepressants (venlafaxine, agomelatine, or fluvoxamine) and…”
Get more information

Prognosis of cognitive deficit progression in aged patients with mild cognitive impairment under prolonged therapy (a three year observation) by Gavrilova, S I, Kolykhalov, I V, Fedorova, Ia B, Kalyn, Ia B, Selezneva, N D, Samorodov, A V, Miasoedov, S N, Boksha, I S

“…The aim of the study was to predict treatment efficacy in patients with mild cognitive impairment (MCI) and to find the most reliable clinical tests for the…”
Get more information

Efficacy, safety and tolerability of a single dose of akatinol memantine in comparison to two-doses in patients with moderately expressed and moderately severe dementia in Alzheimer's disease by Kolykhalov, I V, Gavrilova, S I, Kalyn, Ia B, Selezneva, N D, Fedorova, Ia B

“…The compliance of patients with moderately expressed and moderately severe dementia, caused by Alzheimer's disease (AD), to the treatment with two different…”
Get more information

Possibilities of preventive treatment of Alzheimer's disease: results of the 3-year open prospective comparative study on efficacy and safety of the course therapy with cerebrolysin and cavinton in elderly patients with the syndrome of mild cognitive impairment by Gavrilova, S I, Kolykhalov, I V, Fedorova, Ia B, Selezneva, N D, Kalyn, Ia B, Roshchina, I F, Odinak, M M, Emelin, A Iu, Kashin, A V, Gustov, A V, Antipenko, E A, Korshunova, Iu A, Davydova, T A, Messler, G

“…The study was conducted in 3 Russian centers (Moscow, St. Petersburg and Nizhniy Novgorod). The total sample included 110 patients whose mental state met the…”
Get more information

Efficacy of actovegin in the treatment of elderly patients with vascular mild cognitive impairment by Mikhaĭlova, N M, Selezneva, N D, Kalyn, Ia B, Roshchina, I F, Gavrilova, S I

“…Efficacy of actovegin was investigated in the treatment of mild cognitive impairment (MCI) of cerebrovascular genesis. Thirty patients (7 men and 23 women,…”
Get more information

Clinical heterogeneity of dementias of the Alzheimer's type by Gavrilova, S I, Korsakova, N K, Vavilov, S B, Selezneva, N D, Kalyn YaB, Dybovskaya, N R, Roshchina, I F, Medvedev, L I

Get full text

Ceraxon (citicoline) in the treatment of the mild cognitive impairment syndrome by Gavrilova, S I, Fedorova, Ia B, Gantman, Kalyn, Ia B, Kolykhalov, I V

“…The objective was to study efficacy and safety of ceraxon (citicoline) used perorally in dose 1000 mg daily in the treatment of cognitive disturbances in…”
Get more information

The treatment of Alzheimer's disease in patients with comorbid somatic pathology by Selezneva, N D, Gavrilova, S I, Kalyn, Ia B, Kolykhalov, I V, Fedorova, Ia B

“…To study efficacy and safety of cholinergic therapy in patients with Alzheimer's disease or combined Alzheimer's and vascular dementia and marked somatic…”
Get more information

Content of autoantibodies to bradykinin and beta-amyloid(1-42) as a criterion for biochemical differences between Alzheimer's dementias by Myagkova, M A, Gavrilova, S I, Lermontova, N N, Kalyn, Ya B, Selezneva, N D, Zharikov, G A, Kolykhalov, I V, Abramenko, T V, Serkova, T P, Bachurin, S O

“…We measured serum content of autoantibodies to beta-amyloid protein Abeta(1-42), its neurotoxic fragment Abeta(25-35), vasopressin, bradykinin, thrombin,…”
Get full text

Content of Autoantibodies to Bradykinin and [beta]-Amyloid1-42 as a Criterion for Biochemical Differences between Alzheimer's Dementias by Myagkova, M A, Gavrilova, S I, Lermontova, N N, Kalyn, Ya B, Selezneva, N D, Zharikov, G A, Kolykhalov, I V, Abramenko, T V, Serkova, T P, Bachurin, S O

“…We measured serum content of autoantibodies to beta-amyloid protein Abeta(1-42), its neurotoxic fragment Abeta(25-35), vasopressin, bradykinin, thrombin,…”
Get full text

Autoantibodies to beta-amyloid and neurotransmitters in patients with Alzheimer's disease and senile dementia of the Alzheimer type by Myagkova, M A, Gavrilova, S I, Lermontova, N N, Kalyn, Y B, Selezneva, N D, Zharikov, G A, Kolykhalov, I V, Abramenko, T V, Serkova, T P, Bachurin, S O

“…The content of autoantibodies to beta-amyloid protein Abeta(1-42), its neurotoxic fragment Abeta(25-35), and neurotransmitters were studied in the blood of…”
Get full text

Autoantibodies to [beta]-Amyloid and Neurotransmitters in Patients with Alzheimer's Disease and Senile Dementia of the Alzheimer Type by Myagkova, M A, Gavrilova, S I, Lermontova, N N, Kalyn, Ya B, Selezneva, N D, Zharikov, G A, Kolykhalov, I V, Abramenko, T V, Serkova, T P, Bachurin, S O

“…The content of autoantibodies to beta-amyloid protein Abeta(1-42), its neurotoxic fragment Abeta(25-35), and neurotransmitters were studied in the blood of…”
Get full text

Acetyl-L-carnitine (carnicetine) in the treatment of early stages of Alzheimer's disease and vascular dementia by Gavrilova, S I, Kalyn, Ia B, Kolykhalov, I V, Roshchina, I F, Selezneva, N D

“…Efficacy, safety and tolerability of acetyl-L-carnitine (ALC) were studied during the double-blind placebo-controlled 12-week trial in patients with mild…”
Get more information